Warren Buffett's famous for telling investors to be greedy when others are fearful, but buying Teva Pharmaceuticals Industries (NYSE: TEVA)last year seemed like searching for loose change in a burning building. Generic drug prices began collapsing just after the company borrowed heavily to become the world's largest generic drug producer, and that was just one disaster of manythat forced the company to slash its dividend last year.
Buffett Gets Even Greedier With Teva Pharmaceuticals. Time to Buy?
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться